Product Details for: Breyanzi

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
4.6ML/VIAL
Single-Dose Vial
351(a)
Breyanzi
Rx
Proper Name
lisocabtagene maraleucel
BLA Number
125714
Applicant
Juno Therapeutics, Inc. a Bristol Myer-Squibb Company
Original Approval Date
February 5, 2021
Date of First Licensure
RETURN TO SEARCH RESULTS